In addition, Mirzaei et al. (2021b) demonstrated that by inducing Nrf2 and exerting the anti-oxidative stress ability of Nrf2, it protects cells from cell death and alleviates the side effects of Doxorubicin in tumor patients. The gene discussed is NFE2L2; the disease is neoplasm.